Pyrazoleamide compounds are potent antimalarials that target Na+ homeostasis in intraerythrocytic Plasmodium falciparum
Citations Over TimeTop 1% of 2014 papers
Abstract
The quest for new antimalarial drugs, especially those with novel modes of action, is essential in the face of emerging drug-resistant parasites. Here we describe a new chemical class of molecules, pyrazoleamides, with potent activity against human malaria parasites and showing remarkably rapid parasite clearance in an in vivo model. Investigations involving pyrazoleamide-resistant parasites, whole-genome sequencing and gene transfers reveal that mutations in two proteins, a calcium-dependent protein kinase (PfCDPK5) and a P-type cation-ATPase (PfATP4), are necessary to impart full resistance to these compounds. A pyrazoleamide compound causes a rapid disruption of Na(+) regulation in blood-stage Plasmodium falciparum parasites. Similar effect on Na(+) homeostasis was recently reported for spiroindolones, which are antimalarials of a chemical class quite distinct from pyrazoleamides. Our results reveal that disruption of Na(+) homeostasis in malaria parasites is a promising mode of antimalarial action mediated by at least two distinct chemical classes.
Related Papers
- → African monkeys are infected by Plasmodium falciparum nonhuman primate-specific strains(2011)71 cited
- → Novel quinolinepiperazinyl-aryltetrazoles targeting the blood stage of Plasmodium falciparum(2023)5 cited
- → Use of Molecular Beacon Probes for Real-Time PCR Detection of Plasmodium falciparum and Other Plasmodium Species in Peripheral Blood Specimens(2006)35 cited
- → On the mode of action of phlorizin as an antimalarial agent in in vitro cultures of plasmodium falciparum(1987)71 cited
- → Clags in Plasmodium falciparum and other species of Plasmodium(2001)10 cited